October 30, 2013
WellDoc's BlueStar system.
Baltimore, Maryland-based mobile health company WellDoc has developed a model that can predict hypoglycemic events in patients with Type 2 diabetes 91 percent of the time based on once-a-day patient blood glucose testing.
Predicting hypoglycemic events, a term for when people with diabetes are dangerously low blood sugar, up to 24 hours before they occur -- as...
September 23, 2013
PillPhone: One of the first patient-facing mobile apps to get FDA clearance.
Last week when departing ONC chief Dr. Farzad Mostashari told MobiHealthNews that he thought the FDA should release its final guidance document for mobile medical apps without delay, he might have known something we didn't.
After more than two years since the FDA first published its draft guidance on how it regulates...
September 19, 2013
Over the span of two days last week, Voalte, Audax Health and Google made mobile health hires. Over the span of a month, there have been seven total hiring announcements. While Voalte's new hire has a background in health, some, like Audax's addition of Zynga Chief Operating Officer (COO) David Ko was brought on to grow the company in a new way. MobiHealthNews has compiled a list of all the...
September 3, 2013
Baltimore, Maryland-based mobile health company WellDoc announced a new board of directors this week to help the company further commercialize its recently launched BlueStar product. The new board members include two just retired PricewaterhouseCoopers executives and a Washington insider. Up until now WellDoc's board has largely consisted of the company's own management team, but the new board...
August 22, 2013
This month, Medicare revealed the list of more than 2,000 hospitals losing up to 2 percent of their funding for failing to sufficiently reduce readmissions. Next year, those penalties can rise even higher.
As troubling as this can be for hospitals, it should be good news for mobile health entrepreneurs, as the wake up call may drive hospitals to explore technology like telehealth, remote patient...
August 15, 2013
When Medtronic acquired Minnesota-based home health company Cardiocom last week, it was easy to get confused. Medtronic, a company whose most famous product is an implantable heart monitor, could just as easily have bought Cardiocomm Solutions (two M's), a company with a mobile ECG monitor as its flagship product.
With a boom of young companies and, apparently, only a certain number of health-...
July 1, 2013
A mobile app released last year by Pfizer.
A staggering 90 percent of chronic patients in the US would accept a mobile app prescription from their physician, as opposed to only 66 percent willing to accept a prescription of medication, according to a recent survey from health communications firm Digitas Health. Digitas presented preliminary research findings at a recent event in London, PMLiVE...
June 14, 2013
When Baltimore, Maryland-based WellDoc announced its newest mobile health offering BlueStar this week, the big news was the fact that a "mobile integrated therapy" -- as the company refers to its offerings -- could be prescribed to patients via existing Rx channels and would be paid for by some private health plans.
MobiHealthNews caught up with WellDoc's Chief Strategy and Commercial Officer...
June 13, 2013
Last August -- almost a year ago now -- The New York Times reported that two insurers had agreed to pay $100 a month in reimbursement for use of WellDoc's mobile-enabled diabetes management program. The report, which sourced WellDoc's president Anand Iyer as its source, expected the payers to begin supporting the "mobile integrated therapy" in early 2013.
This morning WellDoc launched a new...
May 1, 2013
Baltimore-based WellDoc has announced the publication of a case study on the integration of it's mobile diabetes management offering with the electronic health record system Allscripts, implemented at George Washington University School of Medicine. Back in 2010, MobiHealthNews reported on the partnership, which was funded by the US Air Force.
WellDoc's diabetes management offering is FDA-cleared...